Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats (Q44948848)

7 December 2017

Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats (English)

1 reference

7 December 2017

1 reference

Jianmin Ran

1

1 reference

PubMed ID

15213064

7 December 2017

Tsutomu Hirano

series ordinal

2

1 reference

PubMed ID

15213064

7 December 2017

Mitsuru Adachi

series ordinal

3

1 reference

7 December 2017

22 June 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 December 2017

1 reference

7 December 2017

287

1 reference

7 December 2017

5

1 reference

7 December 2017

E955-61

1 reference

Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study

7 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

History about the discovery of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin AT1/AT2 receptors: regulation, signalling and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin II induces insulin resistance independent of changes in interstitial insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

Angiotensin and insulin resistance: conspiracy theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00199.2004

10.1152/AJPENDO.00199.2004

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

15213064